de Kraker J - Search Results

1

Radionuclide therapy of neural crest tumors.

Voûte PA, Hoefnagel CA, de Kraker J, Evans AE, Hayes A, Green A. Voûte PA, et al. Among authors: de kraker j. Med Pediatr Oncol. 1987;15(4):192-5. doi: 10.1002/mpo.2950150410. Med Pediatr Oncol. 1987. PMID: 3657706

2

[131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.

Hoefnagel CA, Voûte PA, De Kraker J, Valdés Olmos RA. Hoefnagel CA, et al. Among authors: de kraker j. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):202-6. J Nucl Biol Med (1991). 1991. PMID: 1823819

3

Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").

Hoefnagel CA, de Kraker J, Voûte PA, Valdés Olmos RA. Hoefnagel CA, et al. Among authors: de kraker j. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):248-51. J Nucl Biol Med (1991). 1991. PMID: 1823828

4

Testicular tumor concomitant with von Recklinghausen's disease.

Groot-Loonen JJ, Voûte PA, de Kraker J. Groot-Loonen JJ, et al. Among authors: de kraker j. Med Pediatr Oncol. 1988;16(2):116-7. doi: 10.1002/mpo.2950160210. Med Pediatr Oncol. 1988. PMID: 2832714

5

Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.

Hoefnagel CA, Voûte PA, de Kraker J, Marcuse HR. Hoefnagel CA, et al. Among authors: de kraker j. J Nucl Med. 1987 Mar;28(3):308-14. J Nucl Med. 1987. PMID: 3102701 Free article.

6

131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.

Voûte PA, Hoefnagel CA, de Kraker J. Voûte PA, et al. Among authors: de kraker j. Bull Cancer. 1988;75(1):107-11. Bull Cancer. 1988. PMID: 3359053

7

Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV.

Voûte PA, van der Kleij AJ, De Kraker J, Hoefnagel CA, Tiel-van Buul MM, Van Gennip H. Voûte PA, et al. Among authors: de kraker j. Eur J Cancer. 1995;31A(4):596-600. doi: 10.1016/0959-8049(95)00073-r. Eur J Cancer. 1995. PMID: 7576976 Clinical Trial.

8

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.

De Kraker J, Hoefnagel CA, Caron H, Valdés Olmos RA, Zsiros J, Heij HA, Voûte PA. De Kraker J, et al. Eur J Cancer. 1995;31A(4):600-2. doi: 10.1016/0959-8049(95)00063-o. Eur J Cancer. 1995. PMID: 7576977 Clinical Trial.

9

131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.

Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA. Hoefnagel CA, et al. Among authors: de kraker j. Nucl Med Commun. 1994 Sep;15(9):712-7. doi: 10.1097/00006231-199409000-00008. Nucl Med Commun. 1994. PMID: 7816384 Clinical Trial.

10

[131I]MIBG as a first line treatment in advanced neuroblastoma.

Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA. Hoefnagel CA, et al. Among authors: de kraker j. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):61-4. Q J Nucl Med. 1995. PMID: 9002752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters